Follow
COVID-19
COVID-19 is the disease caused by the novel coronavirus, SARS-CoV-2, which has affected millions of people since its emergence in late 2019. Thought to spread via respiratory droplets, those at higher risk for serious medical complications due to COVID-19 are older adults and those with underlying medical conditions, such as heart disease, lung disease, or diabetes. Symptoms for the disease include fever, shortness of breath, chills, muscle pain, headache, loss of taste/smell, and sore throat.
JUL 16, 2025 | 8:00 AM
The identification of reliable biomarkers from peripheral blood is crucial for improving disease diagnosis and monitoring. Spectral flow cytometry has emerged as a powerful tool for high-dim...
JUN 17, 2025 | 9:00 AM
Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will delve into the importance of accurate and...
FEB 26, 2025 | 8:00 AM
Dr. Fraser's research is focused on the discovery and validation of diagnostic and prognostic biomarkers for complex diseases, including renal dysfunction, long-COVID, and sepsis. By leverag...
JAN 15, 2025 | 7:00 AM
Grab your cup of coffee and join us for the next Multiomics Coffee Break on 15th January at 10.00AM EST/4.00PM CET, with a presentation from Discovery Life Sciences, an Olink Certified Servi...
OCT 16, 2024 | 7:30 AM
C.E. CREDITS
Across the entire spectrum of the life sciences sector, from academia and hospitals to pharmaceutical and biotech companies, enormous amounts of resources are invested in the development of...
SEP 10, 2024 | 9:00 AM
Join us for an insightful webinar exploring how two pioneering public health labs, National Institute of Virology (NIV), India and Fundação Oswaldo Cruz (Fiocruz), Brazil, have...
SEP 04, 2024 | 10:30 AM
C.E. CREDITS
In recent past respiratory seasons, the world witnessed a “tripledemic” of Influenza (flu), SARS-CoV-2 (COVID-19), and Respiratory Syncytial Virus (RSV). In this presentation, I...
JUN 27, 2024 | 7:00 AM
Globally, over 65 million individuals are estimated to suffer from post-acute sequelae of COVID-19 (PASC). A large number of individuals living with PASC experience cardiovascular symptoms (...
MAY 30, 2024 | 9:00 AM
Long COVID, now recognized as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), represents a significant and growing concern in public health and medical communities. As the COVID-19 pande...
MAY 22, 2024 | 9:00 AM
C.E. CREDITS
Tuberculosis (TB) remains a leading global infectious disease killer, second only to COVID-191. It is an airborne disease caused by Mycobacterium tuberculosis bacteria and is responsible for...
MAY 15, 2024 | 2:00 PM
C.E. CREDITS
Laboratories use the same laboratory equipment they invested in for COVID testing to perform PGx testing. With COVID testing reimbursement dropping, many laboratorians are considering implem...
MAY 15, 2024 | 1:00 PM
Join us as we delve into the forefront of SARS-CoV-2 diagnostics and GenScript's transformative impact in the fight against COVID-19. We'll discuss the emergence of COVID-19 and GenS...
MAY 15, 2024 | 9:00 AM
C.E. CREDITS
The last 20 years have seen an explosion of genetic information and data. New technological advances have made it faster and less expensive to understand the human genomes but most of those...
APR 30, 2024 | 2:00 PM
The recognition of mRNA molecules as a transformative class of therapeutic drugs has soared, particularly with the development of COVID 19 mRNA vaccines. The cancer treatment landscape is si...
APR 03, 2024 | 1:00 PM
mRNA vaccines represent a pivotal innovation in prophylactic healthcare, offering a rapid response to emerging infectious diseases. Leveraging the cellular machinery to produce antigenic pro...
On Demand
C.E. CREDITS
The 21st century brought with it an unprecedented number of global and regional economic and political crises, giving rise to a new generation of conflicts in which novel technological, biol...
